Neurokinin-1 Receptor Drives PKCɑ-AURKA/N-myc Signaling to Facilitate the Neuroendocrine Progression of Prostate Cancer

Investigators identified a cell surface receptor neurokinin-1 (NK1R) as a clinically relevant driver of treatment-related neuroendocrine prostate cancer.